Rational therapeutic choices (Introduction to evidence-based medicine and pharmacoeconomy)

wfarm2196  2021-2022  Bruxelles Woluwe

Rational therapeutic choices (Introduction to evidence-based medicine and pharmacoeconomy)
The version you’re consulting is not final. This course description may change. The final version will be published on 1st June.
4 credits
30.0 h + 10.0 h
Q1
Teacher(s)
Language
French
Main themes
- Evidence-based medicine: basic principles; primary and secondary sources of information: methodology and critical appraisal; - Methodology of experimental and observational studies relative to the efficacy and safety of medicines, and critical appraisal; - Methodology of secondary sources of information (systematic reviews, meta-analysis, clinical guidelines), and critical appraisal - Basic principles in pharmacoeconomy and applications to pharmacotherapy - Basic principles relative to health insurance, and to economic factors influencing the use of medicines in Belgium and in Europe
Aims

At the end of this learning unit, the student is able to :

1 At the end of the course, students should be able: - To explain the concept of clinical evidence, and the relative strength of different levels of evidence including data from the scientific literature and other sources of information (such as summary of product characteristics, data from the pharmaceutical industry, recommendations from health authorities,…); - To explain the concept of clinical therapeutic guidelines, and to elaborate on their use in clinical practice ; - To explain the basic principles of pharmacoeconomy and to explain how it can contribute to make rationale therapeutic choices ; - To explain the economic and political principles underlying decisions relative to the use of medicines in Belgium and in Europe, and to debate on the role that pharmacists have with that respect.
 
Content
Part 1. Evidence-based medicine
- basic principles of evidence-based medicine; Primary sources of information (experimental and observational studies); secondary and tertiary sources of information (systematic reviews, meta-analysis, clinical practice guidelines, consesus meetings, other sources of information); drug advertising.
- each part is adressed according to the following questions: what is the evidence? Where can I find them ? How to analyze them critically ?
Part 2. Pharmacoeconomy
Introduction to the Belgian health care system; principles and methods in pharmacoeconomy and in health economic evaluation; drug reimbursement and pricing in Belgium.
Teaching methods
This course includes a mixed approach including lectures, some homework (reading, online exercises), and participation in face-to-face seminars. Teachers pay special attention to making as much as possible the link between theory and practice by illustrating their statements with up-to-date examples concerning different types of drugs.
Evaluation methods
The assessment of learning achievements involves 2 components:
  1. The completion of the online exercises, the participation in the seminars and the results of the simulation test contribute to a part of the evaluation and of the final mark
  2. A written exam with theoretical as well as practical questions relating to the different parts of the course. The skills relating to searching information are assessed through practical questions where the student uses a computer with access to the sources of information seen in the course.
Other information
The participation to the seminars and online exercises is mandatory to validate the course.
Any unjustified absence leads to a penalty on the examination mark that may go up to a cancellation of the examination mark for the academic year (0.20).
In case of repeated absences, even justified, the teacher can propose to the jury to object to the registration to the course examination in accordance with Article 72 of the RGEE.
Teaching materials
  • /
Faculty or entity


Programmes / formations proposant cette unité d'enseignement (UE)

Title of the programme
Sigle
Credits
Prerequisites
Aims
Master [120] in Pharmacy

Master [120] in Statistics: Biostatistics